At the same time, cyclophosphamide was also reported to expand CD11b+ Ly6Chi CCR2hi MDSCs that inhibited long-term tumor control in a murine lymphoma model through the PD-1-PD-L1 axis (133). This evidence concerns the gene CD274 and neoplasm.